B-Cell Receptor Signaling Inhibitors for Treatment of Autoimmune Inflammatory Diseases and B-Cell Malignancies
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
B-Cell Receptor Signaling Inhibitors for Treatment of Autoimmune Inflammatory Diseases and B-Cell Malignancies
Authors
Keywords
-
Journal
INTERNATIONAL REVIEWS OF IMMUNOLOGY
Volume 32, Issue 4, Pages 397-427
Publisher
Informa UK Limited
Online
2013-07-26
DOI
10.3109/08830185.2013.818140
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Isoform-Specific Functions of Phosphoinositide 3-Kinases: p110 but Not p110 Promotes Optimal Allergic Responses In Vivo
- (2014) K. Ali et al. JOURNAL OF IMMUNOLOGY
- B and T Lymphocyte Attenuator Regulates B Cell Receptor Signaling by Targeting Syk and BLNK
- (2014) A. C. Vendel et al. JOURNAL OF IMMUNOLOGY
- Targeting the SYK–BTK axis for the treatment of immunological and hematological disorders
- (2013) Seng-Lai Tan et al. PHARMACOLOGY & THERAPEUTICS
- Ibrutinib (PCI-32765), the First BTK (Bruton’s Tyrosine Kinase) Inhibitor in Clinical Trials
- (2013) Jennifer R. Brown Current Hematologic Malignancy Reports
- Selective pharmacological inhibition of phosphoinositide 3-kinase p110delta opposes the progression of autoimmune diabetes in non-obese diabetic (NOD) mice
- (2012) Caylib A. Durand et al. AUTOIMMUNITY
- Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies
- (2012) A. Agathangelidis et al. BLOOD
- Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia
- (2012) A. Wiestner BLOOD
- Regulating type 1 IFN effects in CD8 T cells during viral infections: changing STAT4 and STAT1 expression for function
- (2012) M. P. Gil et al. BLOOD
- Amplification of Toll-like receptor–mediated signaling through spleen tyrosine kinase in human B-cell activation
- (2012) Shigeru Iwata et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Attenuation of phosphoinositide 3-kinase δ signaling restrains autoimmune disease
- (2012) Mhairi J. Maxwell et al. JOURNAL OF AUTOIMMUNITY
- Rheumatoid arthritis is associated with signaling alterations in naturally occurring autoreactive B-lymphocytes
- (2012) Ganna A. Liubchenko et al. JOURNAL OF AUTOIMMUNITY
- The Syk-binding Ubiquitin Ligase c-Cbl Mediates Signaling-dependent B Cell Receptor Ubiquitination and B Cell Receptor-mediated Antigen Processing and Presentation
- (2012) Bhuvana Katkere et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies
- (2012) Ranjana H. Advani et al. JOURNAL OF CLINICAL ONCOLOGY
- Structural and Biophysical Characterization of the Syk Activation Switch
- (2012) Ulrich Grädler et al. JOURNAL OF MOLECULAR BIOLOGY
- Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
- (2012) Marcus Dühren-von Minden et al. NATURE
- IL-10–Producing Regulatory B10 Cells Inhibit Intestinal Injury in a Mouse Model
- (2011) Koichi Yanaba et al. AMERICAN JOURNAL OF PATHOLOGY
- PI3K inhibitor, GS-1101 (CAL-101), attenuates pathway signaling, induces apoptosis, and overcomes signals from the microenvironment in cellular models of Hodgkin lymphoma
- (2011) S. A. Meadows et al. BLOOD
- SYK inhibition and response prediction in diffuse large B-cell lymphoma
- (2011) S. Cheng et al. BLOOD
- Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
- (2011) S. E. M. Herman et al. BLOOD
- The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia
- (2011) J. Hoellenriegel et al. BLOOD
- Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
- (2011) Cris S Constantinescu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Role of Spleen Tyrosine Kinase Inhibitors in the Management of Rheumatoid Arthritis
- (2011) David L. Scott DRUGS
- Lyn deficiency affects B-cell maturation as well as survival
- (2011) Gitit Shahaf et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignancies
- (2011) Jorge J Castillo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- PI3Kδ drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation
- (2011) Sarah Haylock-Jacobs et al. JOURNAL OF AUTOIMMUNITY
- Fostamatinib, a Syk-Kinase Inhibitor, Does Not Affect Methotrexate Pharmacokinetics in Patients With Rheumatoid Arthritis
- (2011) Muhammad Baluom et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Regulatory B10 Cells Differentiate into Antibody-Secreting Cells After Transient IL-10 Production In Vivo
- (2011) D. Maseda et al. JOURNAL OF IMMUNOLOGY
- Antiarthritis Effect of a Novel Bruton's Tyrosine Kinase (BTK) Inhibitor in Rat Collagen-Induced Arthritis and Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling: Relationships between Inhibition of BTK Phosphorylation and Efficacy
- (2011) L. Liu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Involvement of the Syk–mTOR pathway in follicular lymphoma cell invasion and angiogenesis
- (2011) S Fruchon et al. LEUKEMIA
- Characterization of a model of tracheal plasma extravasation in passively sensitized rats using anti-allergic and anti-inflammatory drugs by oral and intratracheal route
- (2011) Cristina Carreño et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- EAE: imperfect but useful models of multiple sclerosis
- (2011) Bert A. ’t Hart et al. TRENDS IN MOLECULAR MEDICINE
- The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells
- (2011) Betty Y Chang et al. ARTHRITIS RESEARCH & THERAPY
- Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling
- (2011) Chiara Pighi et al. CELLULAR ONCOLOGY
- B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer
- (2010) David J. DiLillo et al. Annals of the New York Academy of Sciences
- An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: A three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents
- (2010) Mark C. Genovese et al. ARTHRITIS AND RHEUMATISM
- The lymph node microenvironment promotes B-cell receptor signaling, NF- B activation, and tumor proliferation in chronic lymphocytic leukemia
- (2010) Y. Herishanu et al. BLOOD
- The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the E - TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling
- (2010) M. Suljagic et al. BLOOD
- PI3K/p110 is a novel therapeutic target in multiple myeloma
- (2010) H. Ikeda et al. BLOOD
- PI3K p110 regulates T-cell cytokine production during primary and secondary immune responses in mice and humans
- (2010) D. R. Soond et al. BLOOD
- CAL-101, a p110 selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability
- (2010) B. J. Lannutti et al. BLOOD
- Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia
- (2010) M. Buchner et al. BLOOD
- Phosphatidylinositol 3-kinase- inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals
- (2010) S. E. M. Herman et al. BLOOD
- Phosphoinositide 3-kinase delta (PI3Kδ) in leukocyte signaling and function
- (2010) Wai-Ping Fung-Leung CELLULAR SIGNALLING
- B-cell tolerance: mechanisms and implications
- (2010) Antony Basten et al. CURRENT OPINION IN IMMUNOLOGY
- Phosphoinositide 3-kinase inhibitor suppresses interleukin-17 expression in a murine asthma model
- (2010) S. J. Park et al. EUROPEAN RESPIRATORY JOURNAL
- Membrane-associated signaling in human B-lymphoma lines
- (2010) Sebastien Tauzin et al. EXPERIMENTAL CELL RESEARCH
- Tyrosines in the Carboxyl Terminus Regulate Syk Kinase Activity and Function
- (2010) Rodrigo O. de Castro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- B Cells Are Required for Optimal CD4+ and CD8+ T Cell Tumor Immunity: Therapeutic B Cell Depletion Enhances B16 Melanoma Growth in Mice
- (2010) D. J. DiLillo et al. JOURNAL OF IMMUNOLOGY
- Therapeutic Targeting of Syk in Autoimmune Diabetes
- (2010) L. Colonna et al. JOURNAL OF IMMUNOLOGY
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
- (2010) R. Eric Davis et al. NATURE
- Specific Btk inhibition suppresses B cell– and myeloid cell–mediated arthritis
- (2010) Julie A Di Paolo et al. Nature Chemical Biology
- The emerging mechanisms of isoform-specific PI3K signalling
- (2010) Bart Vanhaesebroeck et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis
- (2010) Michael E. Weinblatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
- (2010) L. A. Honigberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The PI3K Isoforms p110 and p110 Are Essential for Pre-B Cell Receptor Signaling and B Cell Development
- (2010) F. Ramadani et al. Science Signaling
- Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach
- (2009) M. Niedermeier et al. BLOOD
- B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406
- (2009) M. P. Quiroga et al. BLOOD
- The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy
- (2009) L. Ellis et al. BLOOD
- Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia
- (2009) J. W. Friedberg et al. BLOOD
- Comparison of the anti-allergic activity of Syk inhibitors with optimized Syk siRNAs in FcεRI-activated RBL-2H3 basophilic cells
- (2009) Michael P. Sanderson et al. CELLULAR IMMUNOLOGY
- Translational Mini-Review Series on Th17 Cells: Function and regulation of human T helper 17 cells in health and disease
- (2009) S. Q. Crome et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Modulation of T-Cell Co-Stimulation in Rheumatoid Arthritis
- (2009) Bruno Laganà et al. CLINICAL DRUG INVESTIGATION
- Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD Mice
- (2009) J. A. Emamaullee et al. DIABETES
- B-1 cells modulate the kinetics of wound-healing process in mice☆
- (2009) H.C. Oliveira et al. IMMUNOBIOLOGY
- Bruton’s tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain
- (2009) Abdalla J. Mohamed et al. IMMUNOLOGICAL REVIEWS
- Phosphoinositide 3-Kinase p110 Regulates Natural Antibody Production, Marginal Zone and B-1 B Cell Function, and Autoantibody Responses
- (2009) C. A. Durand et al. JOURNAL OF IMMUNOLOGY
- A Spleen Tyrosine Kinase Inhibitor Reduces the Severity of Established Glomerulonephritis
- (2009) J. Smith et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Role of phosphoinositide 3-kinase p110δ in TLR4- and TLR9-mediated B cell cytokine production and differentiation
- (2009) Nyla Dil et al. MOLECULAR IMMUNOLOGY
- Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies
- (2009) Y.W. Song et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Treatment of rheumatoid arthritis with a syk kinase inhibitor: A twelve-week, randomized, placebo-controlled trial
- (2008) Michael E. Weinblatt et al. ARTHRITIS AND RHEUMATISM
- An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus
- (2008) Frances Rena Bahjat et al. ARTHRITIS AND RHEUMATISM
- Co-stimulatory modulation in rheumatoid arthritis: The role of (CTLA4-Ig) abatacept
- (2008) Ugo Fiocco et al. AUTOIMMUNITY REVIEWS
- Crystal structure of the Bruton’s tyrosine kinase PH domain with phosphatidylinositol
- (2008) Kazutaka Murayama et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk
- (2008) A. Podolanczuk et al. BLOOD
- High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation
- (2008) J. A. Burger et al. BLOOD
- Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target
- (2008) R. M. Young et al. BLOOD
- B lymphocytes: how they develop and function
- (2008) T. W. LeBien et al. BLOOD
- B-cell tolerance checkpoints in health and autoimmunity
- (2008) Eric Meffre et al. CURRENT OPINION IN IMMUNOLOGY
- B-Cells Promote Intra-Islet CD8+ Cytotoxic T-Cell Survival to Enhance Type 1 Diabetes
- (2008) G. M. Brodie et al. DIABETES
- The kinase Syk as an adaptor controlling sustained calcium signalling and B-cell development
- (2008) Yogesh Kulathu et al. EMBO JOURNAL
- Sites and Stages of Autoreactive B Cell Activation and Regulation
- (2008) Mark J. Shlomchik IMMUNITY
- B-lymphocyte contributions to human autoimmune disease
- (2008) Koichi Yanaba et al. IMMUNOLOGICAL REVIEWS
- Regulatory B cells as inhibitors of immune responses and inflammation
- (2008) Jean-David Bouaziz et al. IMMUNOLOGICAL REVIEWS
- A new role for an old player: Do B cells unleash the self-reactive CD8+ T cell storm necessary for the development of type 1 diabetes?
- (2008) Eliana Mariño et al. JOURNAL OF AUTOIMMUNITY
- Molecular Mechanism of the Syk Activation Switch
- (2008) Emily Tsang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Innocuous IFNγ induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production
- (2008) Renu Jain et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells
- (2008) S Gobessi et al. LEUKEMIA
- Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking
- (2008) Linda V Sinclair et al. NATURE IMMUNOLOGY
- Tyr130 phosphorylation triggers Syk release from antigen receptor by long-distance conformational uncoupling
- (2008) Y. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Signal transduction pathways of mantle cell lymphoma: A phosphoproteome-based study
- (2008) Daniela Cecconi et al. PROTEOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started